A carregar...

Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer

The aim of this study was to assess the cost-effectiveness of combination chemotherapy with paclitaxel/cisplatin, compared with standard etoposide/cisplatin in patients with advanced non-small cell lung cancer (NSCLC). We obtained the primary survival and resource utilization data from a large three...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Earle, C C, Evans, W K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1999
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362269/
https://ncbi.nlm.nih.gov/pubmed/10360660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!